KOSPI · Healthcare · ₩404B
₩3,970-2.93%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 7.9% · as of 26.09.11
Among 98 제약 peers
Quarterly Revenue Growth
“새 협력으로 미래 선택지는 넓어졌지만 성과는 더 지켜봐야 해요.”
In the company's words · 2026 2분기 filing